Literature DB >> 28617104

Progress on the clinical application of the SEPT9 gene methylation assay in the past 5 years.

Lele Song1,2, Yuemin Li1.   

Abstract

Entities:  

Keywords:  FIT; SEPT9; adenoma; colorectal cancer; methylation; polyps; septin 9

Mesh：

Substances：

Year:  2017        PMID： 28617104     DOI： 10.2217/bmm-2017-0091

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  8 in total

1.  Genome-wide DNA methylation analysis of colorectal adenomas with and without recurrence reveals an association between cytosine-phosphate-guanine methylation and histological subtypes.

Authors:  David Fiedler; Daniela Hirsch; Nady El Hajj; Howard H Yang; Yue Hu; Carsten Sticht; Indrajit Nanda; Sebastian Belle; Josef Rueschoff; Maxwell P Lee; Thomas Ried; Thomas Haaf; Timo Gaiser
Journal:  Genes Chromosomes Cancer       Date:  2019-08-10       Impact factor: 4.263

2.  A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.

Authors:  María Gallardo-Gómez; Sebastian Moran; María Páez de la Cadena; Vicenta Soledad Martínez-Zorzano; Francisco Javier Rodríguez-Berrocal; Mar Rodríguez-Girondo; Manel Esteller; Joaquín Cubiella; Luis Bujanda; Antoni Castells; Francesc Balaguer; Rodrigo Jover; Loretta De Chiara
Journal:  Clin Epigenetics       Date:  2018-04-16       Impact factor: 6.551

3.  Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer.

Authors:  Bo Fu; Peng Yan; Shan Zhang; Yan Lu; Li Pan; Wenqiang Tang; Shen Chen; Shuangfeng Chen; Anqi Zhang; Wei Liu
Journal:  Dis Markers       Date:  2018-04-23       Impact factor: 3.434

4.  Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test.

Authors:  Ying Chen; Zhenzhen Wang; Guodong Zhao; Chuang Sun; Yong Ma; Linyan Zhang; Minxue Zheng; Hongchun Li
Journal:  Dis Markers       Date:  2019-04-04       Impact factor: 3.434

5.  Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.

Authors:  Guodong Zhao; Hui Li; Zixuan Yang; Zhenzhen Wang; Manqiu Xu; Shangmin Xiong; Shiming Li; XiaoTing Wu; Xiaoyu Liu; Ziwen Wang; Yun Zhu; Yong Ma; Sujuan Fei; Minxue Zheng
Journal:  Cancer Med       Date:  2019-08-12       Impact factor: 4.452

6.  Plasma levels of methylated septin 9 are capable of detecting hepatocellular carcinoma and hepatic cirrhosis.

Authors:  Na He; Gong Feng; Chunyan Zhang; Fangxiong Wu; Ting Zhang; Yongqin Yang
Journal:  Mol Med Rep       Date:  2020-07-23       Impact factor: 2.952

7.  Methylated SFRP2 and SDC2 in stool specimens for Colorectal Cancer early detection: A cost-effective strategy for Chinese population.

Authors:  Guodong Zhao; Xiaoyu Liu; Yi Liu; Yong Ma; Jun Yang; Hui Li; Shangmin Xiong; Sujuan Fei; Minxue Zheng; Xiangwei Zhao
Journal:  J Cancer       Date:  2021-03-05       Impact factor: 4.207

8.  Plasma Methylated RNF180 for Noninvasive Diagnosis of Gastric Cancer.

Authors:  Luyao Zhao; Yandi Liu; Shiwu Zhang; Muran Li
Journal:  Biomed Res Int       Date:  2022-10-05       Impact factor: 3.246
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.